WO2006040465A3 - Nouveau produit, procede et intermediaires de preparation de derives d'azetidine - Google Patents
Nouveau produit, procede et intermediaires de preparation de derives d'azetidine Download PDFInfo
- Publication number
- WO2006040465A3 WO2006040465A3 PCT/FR2005/002490 FR2005002490W WO2006040465A3 WO 2006040465 A3 WO2006040465 A3 WO 2006040465A3 FR 2005002490 W FR2005002490 W FR 2005002490W WO 2006040465 A3 WO2006040465 A3 WO 2006040465A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- intermediates
- azetidine derivatives
- novel product
- azetidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002583992A CA2583992A1 (fr) | 2004-10-14 | 2005-10-10 | Nouveau produit, procede et intermediaires de preparation de derives d'azetidine |
BRPI0516507-5A BRPI0516507A (pt) | 2004-10-14 | 2005-10-10 | produto, processo e intermediários de preparação de derivados de azetidina |
EA200700840A EA011408B1 (ru) | 2004-10-14 | 2005-10-10 | Новый продукт, способ и промежуточные продукты получения производных азетидина |
MX2007003923A MX2007003923A (es) | 2004-10-14 | 2005-10-10 | Nuevo producto, procedimiento e intermediarios de preparacion de derivados de azetidina. |
AU2005293454A AU2005293454A1 (en) | 2004-10-14 | 2005-10-10 | Novel product, method and intermediates for the preparation of azetidine derivatives |
EP05809232A EP1805167A2 (fr) | 2004-10-14 | 2005-10-10 | Nouveau produit, procede et intermediaires de preparation de derives d'azetidine |
JP2007536214A JP2008516932A (ja) | 2004-10-14 | 2005-10-10 | アゼチジン誘導体調製のための新規な生成物、方法および中間体 |
IL181904A IL181904A0 (en) | 2004-10-14 | 2007-03-13 | Novel product, method and intermediates for the preparation of azetidine derivatives |
TNP2007000097A TNSN07097A1 (fr) | 2004-10-14 | 2007-03-16 | Nouveau produit, procede et intermediaires de preparation de derives d'azetidine |
EC2007007332A ECSP077332A (es) | 2004-10-14 | 2007-03-21 | Nuevo producto, procedimiento e intermediarios de preparación de derivados de azetidina |
US11/689,588 US7687493B2 (en) | 2004-10-14 | 2007-03-22 | Product, method and intermediates for the preparation of azetidine derivatives |
NO20072192A NO20072192L (no) | 2004-10-14 | 2007-04-27 | Nytt produkt, fremgangsmate og mellomprodukter for fremstilling av azetidinderivater |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0410844A FR2876688B1 (fr) | 2004-10-14 | 2004-10-14 | Nouveau produit, procede et intermediaires de preparation de derives d'azetidine |
FR0410844 | 2004-10-14 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/689,588 Continuation US7687493B2 (en) | 2004-10-14 | 2007-03-22 | Product, method and intermediates for the preparation of azetidine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006040465A2 WO2006040465A2 (fr) | 2006-04-20 |
WO2006040465A3 true WO2006040465A3 (fr) | 2006-08-10 |
Family
ID=34954419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2005/002490 WO2006040465A2 (fr) | 2004-10-14 | 2005-10-10 | Nouveau produit, procede et intermediaires de preparation de derives d'azetidine |
Country Status (21)
Country | Link |
---|---|
US (1) | US7687493B2 (fr) |
EP (1) | EP1805167A2 (fr) |
JP (1) | JP2008516932A (fr) |
KR (1) | KR20070063544A (fr) |
CN (1) | CN101039931A (fr) |
AR (1) | AR051390A1 (fr) |
AU (1) | AU2005293454A1 (fr) |
BR (1) | BRPI0516507A (fr) |
CA (1) | CA2583992A1 (fr) |
EA (1) | EA011408B1 (fr) |
EC (1) | ECSP077332A (fr) |
FR (1) | FR2876688B1 (fr) |
IL (1) | IL181904A0 (fr) |
MA (1) | MA29513B1 (fr) |
MX (1) | MX2007003923A (fr) |
NO (1) | NO20072192L (fr) |
SG (1) | SG155193A1 (fr) |
TN (1) | TNSN07097A1 (fr) |
TW (1) | TW200630358A (fr) |
WO (1) | WO2006040465A2 (fr) |
ZA (1) | ZA200702528B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113045539B (zh) * | 2021-03-30 | 2021-12-07 | 苏州大学 | 2-(4,4-二氯-1-(8-喹啉基)-2-氮杂环丁基)羧酸酯衍生物的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001064634A1 (fr) * | 2000-03-03 | 2001-09-07 | Aventis Pharma S.A. | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8709887D0 (en) * | 1987-04-27 | 1987-06-03 | Univ Alberta | Alkyl azodicarboxylates |
US5530134A (en) * | 1994-09-06 | 1996-06-25 | Synphar Laboratories Inc. | Synthesis of anabaseine, salts and derivatives thereof |
US6355631B1 (en) * | 2000-03-03 | 2002-03-12 | Aventis Pharma S.A. | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation |
NZ524618A (en) * | 2000-08-10 | 2004-08-27 | Mitsubishi Pharma Corp | Proline derivatives and use thereof as drugs |
CN1874991A (zh) * | 2003-08-29 | 2006-12-06 | 小野药品工业株式会社 | 能够结合s1p受体的化合物及其药物用途 |
-
2004
- 2004-10-14 FR FR0410844A patent/FR2876688B1/fr not_active Expired - Fee Related
-
2005
- 2005-10-10 EA EA200700840A patent/EA011408B1/ru not_active IP Right Cessation
- 2005-10-10 MX MX2007003923A patent/MX2007003923A/es active IP Right Grant
- 2005-10-10 EP EP05809232A patent/EP1805167A2/fr not_active Withdrawn
- 2005-10-10 JP JP2007536214A patent/JP2008516932A/ja active Pending
- 2005-10-10 CN CNA2005800350837A patent/CN101039931A/zh active Pending
- 2005-10-10 ZA ZA200702528A patent/ZA200702528B/xx unknown
- 2005-10-10 KR KR1020077008461A patent/KR20070063544A/ko not_active Application Discontinuation
- 2005-10-10 WO PCT/FR2005/002490 patent/WO2006040465A2/fr active Application Filing
- 2005-10-10 SG SG200905236-6A patent/SG155193A1/en unknown
- 2005-10-10 CA CA002583992A patent/CA2583992A1/fr not_active Abandoned
- 2005-10-10 AU AU2005293454A patent/AU2005293454A1/en not_active Withdrawn
- 2005-10-10 BR BRPI0516507-5A patent/BRPI0516507A/pt not_active IP Right Cessation
- 2005-10-13 TW TW094135607A patent/TW200630358A/zh unknown
- 2005-10-13 AR ARP050104296A patent/AR051390A1/es unknown
-
2007
- 2007-03-13 IL IL181904A patent/IL181904A0/en unknown
- 2007-03-16 TN TNP2007000097A patent/TNSN07097A1/fr unknown
- 2007-03-21 EC EC2007007332A patent/ECSP077332A/es unknown
- 2007-03-22 US US11/689,588 patent/US7687493B2/en not_active Expired - Fee Related
- 2007-04-27 NO NO20072192A patent/NO20072192L/no not_active Application Discontinuation
- 2007-05-11 MA MA29896A patent/MA29513B1/fr unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001064634A1 (fr) * | 2000-03-03 | 2001-09-07 | Aventis Pharma S.A. | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
Also Published As
Publication number | Publication date |
---|---|
US7687493B2 (en) | 2010-03-30 |
WO2006040465A2 (fr) | 2006-04-20 |
ECSP077332A (es) | 2007-04-26 |
US20070270463A1 (en) | 2007-11-22 |
EA011408B1 (ru) | 2009-02-27 |
AR051390A1 (es) | 2007-01-10 |
FR2876688B1 (fr) | 2007-03-16 |
CN101039931A (zh) | 2007-09-19 |
NO20072192L (no) | 2007-04-27 |
CA2583992A1 (fr) | 2006-04-20 |
KR20070063544A (ko) | 2007-06-19 |
FR2876688A1 (fr) | 2006-04-21 |
SG155193A1 (en) | 2009-09-30 |
JP2008516932A (ja) | 2008-05-22 |
TW200630358A (en) | 2006-09-01 |
BRPI0516507A (pt) | 2008-09-16 |
MX2007003923A (es) | 2007-06-07 |
AU2005293454A1 (en) | 2006-04-20 |
IL181904A0 (en) | 2007-07-04 |
MA29513B1 (fr) | 2008-06-02 |
TNSN07097A1 (fr) | 2008-06-02 |
ZA200702528B (en) | 2008-07-30 |
EA200700840A1 (ru) | 2007-08-31 |
EP1805167A2 (fr) | 2007-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003093269A3 (fr) | Pyrazolopyrimidine-4-one substituee | |
WO2003104473A3 (fr) | Galactosyl-isomalte, son procede de preparation et son utilisation | |
IL176547A0 (en) | 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity | |
WO2003070725A3 (fr) | Procede de preparation de derives de l'indolinone | |
WO2007119106A3 (fr) | Procédés de préparation de composés intermédiaires utilisés dans la préparation de l'ézétimibe | |
WO2006066839A3 (fr) | Procede pour produire des pyrrolidones a partir de succinates issus de bouillons de fermentation | |
TW200745039A (en) | Isotopically substituted pantoprazole | |
WO2006061215A3 (fr) | 2-alkyl-cycloalk(en)yl-carboxamides | |
WO2007073888A3 (fr) | Composition pharmaceutique contenant de l'hydrochlorure de donepezil, comprime a base de cette composition et procede de production associe | |
WO2004106307A3 (fr) | Nouveaux derives d’imidazoles, leur preparation et leur utilisation en tant que medicament | |
WO2008074693A3 (fr) | Procédé de préparation de 3,5-di-omicron-acyl-2-fluoro-2-c-méthyl-d-ribono-gamma-lactone | |
MX2007004483A (es) | Metodo y productos intermediarios para la preparacion de derivados de n-(1-benzhidril-azetidin-3-il)-n- fenilmetilsulfonamida. | |
WO2004056769A3 (fr) | Synthèse d'amines et intermédiaires pour cette synthèse | |
WO2006040465A3 (fr) | Nouveau produit, procede et intermediaires de preparation de derives d'azetidine | |
ZA200303189B (en) | Method for producing a piece of timber including heartwood. | |
WO2005042480A3 (fr) | Pyrazolylcarboxanilides n-substitues | |
WO2006036498A3 (fr) | Procede de preparation de pyrazoles 1,3,5-trisubstitues par [3+2] cycloaddition | |
AU2003235814A8 (en) | Novel process for the preparation of trans-3- ethyl-2,5- dihydro-4- methyl-n-(2-( 4-(((((4-methyl cyclohexyl) amino)carbonyl) amino)sulfonyl) phenyl)ethyl) -2-oxo-1h-pyrrole -1-carboxamide | |
IL182445A0 (en) | Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4difluoromethoxy-8-methanesulfona mido-dibenzo[b,d]furan-1-caboxamide | |
WO2006090265A3 (fr) | Procedes de preparation de levetiracetam, son intermediaire et utilisation de levetiracetam dans des compositions pharmaceutiques | |
WO2006000009A3 (fr) | Oxyde ferrique lamellaire | |
EP1841739B8 (fr) | Procédé de synthèse de la 1-benzyl-4-[(5,6-diméthoxy-1-indanon--2-yl)méthyl]pipéridine ou de son sel via un nouvel intermédiaire | |
WO2007057703A3 (fr) | Procede et intermediaires pour la preparation de statines | |
WO2003080567A3 (fr) | Produits intermediaires destines a la synthese de la discodermolide et de ses analogues, et leurs procedes de preparation | |
WO2004091474A3 (fr) | Procedes de preparation de derives de la dhea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 181904 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 553951 Country of ref document: NZ Ref document number: 12007500619 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: DZP2007000188 Country of ref document: DZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005293454 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11689588 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007/02528 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/003923 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1275/KOLNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2583992 Country of ref document: CA Ref document number: 07036349 Country of ref document: CO |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007536214 Country of ref document: JP Ref document number: 200580035083.7 Country of ref document: CN Ref document number: 1020077008461 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2005293454 Country of ref document: AU Date of ref document: 20051010 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005293454 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005809232 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1200700991 Country of ref document: VN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200700840 Country of ref document: EA |
|
WWP | Wipo information: published in national office |
Ref document number: 2005809232 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 11689588 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0516507 Country of ref document: BR |